North America Veterinary Capital Equipment Market

By Product Type (Veterinary Anesthesia, Surgical Lights, Veterinary Monitors, Veterinary Tables, Veterinary Telemetry Systems, Dental Equipment, Infusion Pumps and Others) – Industry Demand Analysis & Opportunity Assessment 2016–2025

Buy Now
Report ID: 1256 | Published On: Feb 06, 2023
Request Free Sample Copy

Market Segmentation Synopsis

By Product Type

The North America veterinary capital equipment market has been segmented by product type into veterinary anesthesia (veterinary anesthesia machines, anesthesia ventilators, anesthesia vaporizers and others), surgical lights (operating room light, diagnostic and handheld lights and headlights), veterinary monitors (vital signs monitors, anesthesia gas monitors and others), veterinary tables (surgical tables, veterinary exam & procedure tables and others), veterinary telemetry systems, dental equipment, infusion pumps and others. Among these segments, the veterinary telemetry systems segment is estimated to achieve absolute $ opportunity of USD 72.92 Million during 2018-2025. Further, the number of infusion pumps is expected to increase in North America on the account of their ability to deliver nutrients or medications in animal’s body at a faster pace and less painfully as compared to the manual way of doing it.

North America Veterinary Capital Equipment Market Share (%), By Product Type

North America Veterinary Capital Equipment Market by country
Get more information on this report: Request Sample PDF

Market Overview and Growth Highlights

Diseases such as avian influenza, contagious equine metritis, tuberculosis and others have been occurring in animals over the years. Rising incidences of zoonotic diseases are increasing the chances of diseases in pets as well as humans and pose a serious risk to animal and human health. Further, due to rising cases of infectious diseases, the regular pet and other animal diagnostic rate is improving across U.S. Along with that, rising number of pet owners and swelled U.S. pet industry spending are expected to emerge as a major driving factor behind the growth of the North America veterinary capital equipment market. The North America veterinary capital equipment market accounted for USD 800.3 Million in 2016 and is expected to reach USD 1136.4 Million by the end of 2025. Further, the North America veterinary capital equipment market is estimated to witness a notable CAGR of 4.2% over the forecast period 2018-2025.

The United States held the dominant share of around 85% during 2016 in the North America region. The technological advancements in veterinary equipment and rapid introduction of advanced veterinary equipment are also bolstering the demand for veterinary capital equipment across U.S. In addition to this, continuous rise in number of veterinarians in the United States is also expected to create business opportunities for veterinary capital equipment manufactures in the region.

North America Veterinary Capital Equipment Market by country

Get more information on this report: Download Sample PDF

Market Drivers & Challenges

Growth Indicators

The number of active veterinarians in U.S. has been increasing over the past years. These veterinarians are engaged in vet healthcare activities such as animal research, clinical practices and others. This rising number of veterinarians is fuelling the demand for veterinary capital equipment. Thus, increasing demand for new veterinary capital equipment among veterinarians is expected to foster the growth of the veterinary capital equipment market in North America over the forecast period. Further, the infection rate among pet animals has been continuously increasing which is expected to increase the number of patients in veterinary hospitals in the upcoming years. Apart from this, diagnostic equipment such as X-ray machines, ultrasound scanners, microscopes and others are showcasing great potential for the future growth owing to the rising visiting rate of patients in the animal hospitals.

Additionally, the increasing U.S. pet industry expenditure is also believed to aid the North America veterinary capital equipment market to grow in near future.


Capital equipment such as C-arms, x-ray imaging systems are very costly because of which the small hospitals and private facilities are refraining from large scale investments in these equipment. High cost of advanced and giant veterinary equipment is expected to limit the growth of the North America veterinary capital equipment market.

North America Veterinary Capital Equipment Market Share (%), By Product Type
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating The Market

    Some of the affluent industry leaders in the North America veterinary capital equipment market are Smiths Medical, Medtronic Plc., Abaxis, Welch Allyn, Bovie Medical, DRE Veterinary, VETLAND Medical, Midmark Corporation and Digicare Biomedical Technology, Inc.

    The companies are actively getting engaged in the launch of new products to gain competitive edge over other players. Further, the veterinary capital equipment manufacturers are continuously looking for potential acquisitions to strengthen their position in the market and are expanding their presence and production capacity in order to survive in this highly competitive market of veterinary capital equipment. In addition to that, manufacturers of veterinary capital equipment in North America are increasingly looking forward to strengthen their distribution channel through initiatives such as offering their products under other distributors or through their own online stores among other platforms.

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample